Pretty detailed.... I don’t see harboring any n
Post# of 36537
I don’t see harboring any notions re covid vaccine development unless and until we know whether iikey actually works. Maybe it does, or maybe the peptide investigation is going more slowly that anticipated, or maybe it’s just flopped. I don’t see anyone bothering to complete work on a contract until they and we know that the iikey peptide investigation yielded something sufficiently positive that there will actually be clinical trials for a vaccine.
In the interim, I do want to hear about are the new healthcare delivery platform, excellagen, Altucel and more...things that will not depend on a long shot vaccine development opportunity. Where are the PRs on the rest of the family?